TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
medmix AG ( (CH:MEDX) ) has issued an update.
medmix AG has announced a strategic partnership with Gurit to enhance sustainable solutions for industrial bonding applications. This collaboration combines Gurit’s advanced adhesive technology with medmix’s sustainable cartridge systems, aiming to meet the growing demand for performance and sustainability across various sectors, thereby strengthening medmix’s position in sustainable dispensing technology.
The most recent analyst rating on (CH:MEDX) stock is a Hold with a CHF11.00 price target. To see the full list of analyst forecasts on medmix AG stock, see the CH:MEDX Stock Forecast page.
More about medmix AG
medmix is a global leader in high-precision delivery devices, serving healthcare, consumer, and industrial markets. The company is known for its innovation and technological advancements, with over 900 active patents and 14 production sites worldwide. Headquartered in Baar, Switzerland, medmix is dedicated to providing high-quality, agile solutions to its customers.
Average Trading Volume: 58,605
Technical Sentiment Signal: Strong Sell
Current Market Cap: CHF415.1M
For detailed information about MEDX stock, go to TipRanks’ Stock Analysis page.